190 related articles for article (PubMed ID: 25395067)
21. Distinct profile of HIF1α, PTCH, EphB2, or DNA repair protein expression and BRAF mutation in colorectal serrated adenoma.
Morimoto T; Mitomi H; Saito T; Takahashi M; Murakami T; Sakamoto N; Yao T; Watanabe S
J Gastroenterol Hepatol; 2014 Jun; 29(6):1192-9. PubMed ID: 24612059
[TBL] [Abstract][Full Text] [Related]
22. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.
Boparai KS; Dekker E; Polak MM; Musler AR; van Eeden S; van Noesel CJ
Am J Pathol; 2011 Jun; 178(6):2700-7. PubMed ID: 21641392
[TBL] [Abstract][Full Text] [Related]
23. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
[TBL] [Abstract][Full Text] [Related]
24. Frequent activating GNAS mutations in villous adenoma of the colorectum.
Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y
J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786
[TBL] [Abstract][Full Text] [Related]
25. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
Yang S; Farraye FA; Mack C; Posnik O; O'Brien MJ
Am J Surg Pathol; 2004 Nov; 28(11):1452-9. PubMed ID: 15489648
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
[TBL] [Abstract][Full Text] [Related]
27. Hyperplastic polyps of the colon and rectum - reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma.
Janjua HG; Høgdall E; Linnemann D
APMIS; 2015 Apr; 123(4):298-304. PubMed ID: 25708741
[TBL] [Abstract][Full Text] [Related]
28. Hyperplastic polyps identified during screening endoscopy: reevaluated by histological examinations and genetic alterations.
Lin YC; Chiu HM; Lee YC; Shun CT; Wang HP; Wu MS
J Formos Med Assoc; 2014 Jul; 113(7):417-21. PubMed ID: 24961182
[TBL] [Abstract][Full Text] [Related]
29. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J
Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389
[TBL] [Abstract][Full Text] [Related]
30. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
[TBL] [Abstract][Full Text] [Related]
31. Tracing origin of serrated adenomas with BRAF and KRAS mutations.
Lee EJ; Choi C; Park CK; Maeng L; Lee J; Lee A; Kim KM
Virchows Arch; 2005 Sep; 447(3):597-602. PubMed ID: 15991007
[TBL] [Abstract][Full Text] [Related]
32. Traditional serrated adenoma: an update.
Bettington ML; Chetty R
Hum Pathol; 2015 Jul; 46(7):933-8. PubMed ID: 26001333
[TBL] [Abstract][Full Text] [Related]
33. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
Kim YH; Kakar S; Cun L; Deng G; Kim YS
Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical Examination is Highly Sensitive and Specific for Detection of the V600E BRAF Mutation in Colorectal Serrated Lesions.
Yamada N; Eizuka M; Sugimoto R; Tanaka Y; Yanagawa N; Yamano H; Suzuki H; Matsumoto T; Sugai T
Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):446-453. PubMed ID: 33306619
[TBL] [Abstract][Full Text] [Related]
35. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH
World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422
[TBL] [Abstract][Full Text] [Related]
36. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
[TBL] [Abstract][Full Text] [Related]
37. Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions.
Tsai JH; Cheng CH; Chen CC; Lin YL; Lin LI; Chen ML; Liau JY
Histopathology; 2016 May; 68(6):810-8. PubMed ID: 26496853
[TBL] [Abstract][Full Text] [Related]
38. Serrated adenoma: a distinct form of non-polypoid colorectal neoplasia?
Noffsinger AE; Hart J
Gastrointest Endosc Clin N Am; 2010 Jul; 20(3):543-63. PubMed ID: 20656251
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
Spring KJ; Zhao ZZ; Karamatic R; Walsh MD; Whitehall VL; Pike T; Simms LA; Young J; James M; Montgomery GW; Appleyard M; Hewett D; Togashi K; Jass JR; Leggett BA
Gastroenterology; 2006 Nov; 131(5):1400-7. PubMed ID: 17101316
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of colorectal adenomas, the serrated adenoma, and implications for screening and surveillance.
Freeman HJ
World J Gastroenterol; 2008 Jun; 14(22):3461-3. PubMed ID: 18567071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
